Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Exosome therapy shows promise for hair growth but needs human trials for validation.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Transplant patients often get skin problems, with treatments varying by condition.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Hydroxychloroquine can help treat certain types of hair loss.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Trichoscopy helps diagnose and monitor the treatment of fungal scalp infections in children.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.